Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiang Yan

Showing results (631-640 of 948) with videos related to

Pageof 95
Sort By:
Stroke|November 15, 2011
Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) studyQiao Shu Wang, Christopher Chen, Xiang Yan Chen, et al.
The Journal of International Medical Research|August 27, 2013
The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancerXiao-Peng He, Fu-Jie Song, Xiang-Yan Liu, et al.
Oncology Letters|September 1, 2020
GLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancerZhouhuan Dong, Yun Wang, Vivianne Ding, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2025
Induction therapy with dabrafenib, trametinib, and PD-1 inhibitor and surgical conversion in unresectable stage III non-small cell lung cancers with BRAF V600E mutation: 2 casesSida Cheng, Ruijie Zhang, Feng Yang, et al.
Oncology Letters|November 23, 2017
Yi-qi-yang-yin-tang increases the sensitivity of KG1a leukemia stem cells to daunorubicin by promoting cell cycle progression and regulating the expression of PTEN, TOPOII and mTORZhe-Xin Shi, Hong-Yu Li, Xiang-Dong Yang, et al.
Frontiers in Pharmacology|November 3, 2017
Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-AnalysisPeng-Fei Wang, Yang Chen, Si-Ying Song, et al.
Oncotargets and Therapy|December 14, 2020
Profiling Analysis Reveals the Crucial Role of the Endogenous Peptides in Bladder Cancer ProgressionWeijian Li, Yang Zhang, Youjian Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 2, 2018
Grifolic acid causes osteosarcoma cell death in vitro and in tumor-bearing miceYu-Feng Zhao, Feng Jiang, Xiang-Yan Liang, et al.
Chinese Medical Journal|February 1, 2023
Prevalence of maturity-onset diabetes of the young in phenotypic type 2 diabetes in young adults: a nationwide, multi-center, cross-sectional survey in ChinaYan Chen, Jing Zhao, Xia Li, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2009
[Inhibitory effects of thiazolidinedione upon cytokine-induced apoptosis in pancreatic beta-cell line]An-Ping Wang, Xia Li, Bi-Lian Liu, et al.
Pageof 95

Showing results (631-640 of 948) with videos related to

Sort By:
Pageof 95
Stroke|November 15, 2011
Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) studyQiao Shu Wang, Christopher Chen, Xiang Yan Chen, et al.
The Journal of International Medical Research|August 27, 2013
The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancerXiao-Peng He, Fu-Jie Song, Xiang-Yan Liu, et al.
Oncology Letters|September 1, 2020
GLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancerZhouhuan Dong, Yun Wang, Vivianne Ding, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2025
Induction therapy with dabrafenib, trametinib, and PD-1 inhibitor and surgical conversion in unresectable stage III non-small cell lung cancers with BRAF V600E mutation: 2 casesSida Cheng, Ruijie Zhang, Feng Yang, et al.
Oncology Letters|November 23, 2017
Yi-qi-yang-yin-tang increases the sensitivity of KG1a leukemia stem cells to daunorubicin by promoting cell cycle progression and regulating the expression of PTEN, TOPOII and mTORZhe-Xin Shi, Hong-Yu Li, Xiang-Dong Yang, et al.
Frontiers in Pharmacology|November 3, 2017
Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-AnalysisPeng-Fei Wang, Yang Chen, Si-Ying Song, et al.
Oncotargets and Therapy|December 14, 2020
Profiling Analysis Reveals the Crucial Role of the Endogenous Peptides in Bladder Cancer ProgressionWeijian Li, Yang Zhang, Youjian Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 2, 2018
Grifolic acid causes osteosarcoma cell death in vitro and in tumor-bearing miceYu-Feng Zhao, Feng Jiang, Xiang-Yan Liang, et al.
Chinese Medical Journal|February 1, 2023
Prevalence of maturity-onset diabetes of the young in phenotypic type 2 diabetes in young adults: a nationwide, multi-center, cross-sectional survey in ChinaYan Chen, Jing Zhao, Xia Li, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2009
[Inhibitory effects of thiazolidinedione upon cytokine-induced apoptosis in pancreatic beta-cell line]An-Ping Wang, Xia Li, Bi-Lian Liu, et al.
Pageof 95